Company: CORT
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001628280-25-037005
Chunk: 0

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-07-31
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
ITEM 1.  FINANCIAL STATEMENTS

CORCEPT THERAPEUTICS INCORPORATED

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)June 30,2025December 31,2024 (Unaudited)(See Note 1)ASSETS  Current assets:  Cash and cash equivalents$102,745 $127,665 Short-term marketable securities239,481 255,669 Trade receivables, net of allowances64,567 53,976 Inventory12,276 12,412 Prepaid expenses and other current assets24,043 21,880 Total current assets443,112 471,602 Strategic inventory7,991 3,583 Operating lease right-of-use asset4,964 5,324 Property and equipment, net2,348 2,689 Long-term marketable securities172,775 219,831 Other assets8,303 6,610 Deferred tax assets, net162,229 130,914 Total assets$801,722 $840,553 LIABILITIES AND STOCKHOLDERS’ EQUITYCurrent liabilities:Accounts payable$23,525 $15,376 Accrued research and development expenses29,049 33,868 Accrued and other liabilities91,073 90,700 Short-term operating lease liability1,017 829 Total current liabilities144,664 140,773 Long-term operating lease liability5,588 6,107 Long-term accrued income taxes payable15,677 14,084 Total liabilities165,929 160,964 Commitments and contingencies (Note 4)Stockholders’ equity:Preferred stock— — Common stock138 136 Treasury stock(866,931)(696,173)Additional paid-in capital900,864 832,108 Accumulated other comprehensive income (loss)2,291 (217)Retained earnings599,431 543,735 Total stockholders’ equity635,793 679,589 Total liabilities and stockholders’ equity$801,722 $840,553 

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

CORCEPT THERAPEUTICS INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(In thousands, except per share data)Three Months Ended